Actively Recruiting
Lymphatic Mapping Of Oropharyngeal Cancer
Led by University College, London · Updated on 2024-09-19
150
Participants Needed
2
Research Sites
234 weeks
Total Duration
On this page
Sponsors
U
University College, London
Lead Sponsor
N
National Institute for Health Research, United Kingdom
Collaborating Sponsor
AI-Summary
What this Trial Is About
A multi-centre validation study to evaluate whether a new imaging and surgical protocol would work as well as the current gold standard in identifying sentinel nodes in patients with oropharyngeal cancer.
CONDITIONS
Official Title
Lymphatic Mapping Of Oropharyngeal Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 or over
- New diagnosis of oropharyngeal cancer including all anatomical subsites and HPV status
- Unilateral metastatic lymph nodes matching AJCC TNM8 staging N1-N2b for P16 negative or N1 for P16 positive patients
You will not qualify if you...
- Suspicious bilateral lymph nodes on imaging
- Previous radiotherapy or surgery to the neck
- Second primary oropharyngeal tumors
- Presence of distant metastasis such as in lung or bone
- Pregnancy or lactation
- Inability to give informed consent
- Allergy to lymphatic tracer substances
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
St George's University Hospitals NHS Foundation Trust
London, United Kingdom, SW17 0QT
Actively Recruiting
2
University College Hospital
London, United Kingdom
Actively Recruiting
Research Team
T
Trial Manager
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here